Clinical Trial Update: HRS9531 Controls Weight Regain in Obese Subjects [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for HRS9531 aiming to control weight regain in obese subjects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• HRS9531

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Obesity | Phase 2 | Status: UNKNOWN